|
WO2016141480A1
|
|
Tools and methods for using cell division loci to control proliferation of cells
|
|
WO2014138917A1
|
|
Methods to determine activation states of receptor tyrosine kinase mediated signaling networks for sample classification
|
|
WO2012094739A1
|
|
Methods for repairing cartilage
|
|
WO2012021969A1
|
|
Markers of the male urogenital tract
|
|
WO2012000094A1
|
|
REAGENTS AND METHODS FOR DIAGNOSING CONDITIONS ASSOCIATED WITH HYDROXYLATED HIF 1-α
|
|
CA2737485A1
|
|
Methods for classifying samples based on network modularity
|
|
WO2010012077A1
|
|
Compositions, methods and kits for reprogramming somatic cells
|
|
WO2009036566A1
|
|
Methods for detecting abnormalities in breast tissue using aromatase inhibitors
|
|
WO2009003291A1
|
|
Therapeutics and diagnostics for group a streptococci
|
|
WO2008104064A1
|
|
Compositions and methods for treating peripheral vascular diseases
|
|
WO2008104065A1
|
|
Neural cell preparations and methods of making and using them
|
|
CA2678422A1
|
|
Fibrous scaffold for use in soft tissue engineering
|
|
CA2613814A1
|
|
Method and system for communicating patient information
|
|
US2011150916A1
|
|
Compositions and methods for treatment of group a streptococci
|
|
US2008038269A1
|
|
Methods for detecting and treating kidney disease
|
|
CA2582761A1
|
|
Markers of pre-term labor
|
|
EP2122018A2
|
|
Diagnostic compositions and treatment methods for conditions involving tro-phoblast cell death, differentiation, invasion and/or cell fusion and turnover
|
|
US2007244071A1
|
|
Treatment of proliferative diseases
|
|
WO2007056851A1
|
|
Compositions and methods for enhancing ovulation inducing agents
|
|
CA2612191A1
|
|
Methods and compositions for enhancing developmental potential of oocytes and preimplantation embryos
|
